147 related articles for article (PubMed ID: 19591084)
1. [Treatment of respiratory papillomatosis--a case report on systemic treatment with bevacizumab].
Nagel S; Busch C; Blankenburg T; Schütte W
Pneumologie; 2009 Jul; 63(7):387-9. PubMed ID: 19591084
[TBL] [Abstract][Full Text] [Related]
2. Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience.
Maturo S; Hartnick CJ
Arch Otolaryngol Head Neck Surg; 2010 Jun; 136(6):561-5. PubMed ID: 20566906
[TBL] [Abstract][Full Text] [Related]
3. High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis.
Sidell DR; Nassar M; Cotton RT; Zeitels SM; de Alarcon A
Ann Otol Rhinol Laryngol; 2014 Mar; 123(3):214-21. PubMed ID: 24633948
[TBL] [Abstract][Full Text] [Related]
4. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey.
Best SR; Mohr M; Zur KB
Laryngoscope; 2017 Oct; 127(10):2225-2229. PubMed ID: 28657692
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child.
Zur KB; Fox E
Laryngoscope; 2017 Jul; 127(7):1538-1542. PubMed ID: 27996119
[TBL] [Abstract][Full Text] [Related]
6. Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study.
Zeitels SM; Barbu AM; Landau-Zemer T; Lopez-Guerra G; Burns JA; Friedman AD; Freeman MW; Halvorsen YD; Hillman RE
Ann Otol Rhinol Laryngol; 2011 Oct; 120(10):627-34. PubMed ID: 22097147
[TBL] [Abstract][Full Text] [Related]
7. Preliminary report of endolaryngeal and endotracheal laser surgery of juvenile-onset recurrent respiratory papillomatosis by Nd:YAG laser and a new fiber guidance instrument.
Janda P; Leunig A; Sroka R; Betz CS; Rasp G
Otolaryngol Head Neck Surg; 2004 Jul; 131(1):44-9. PubMed ID: 15243556
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
9. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
So RJ; Rayle C; Joo HH; Huang EY; Seiwert TY; Raabe EH; Best SR
Laryngoscope; 2024 Jul; 134(7):3253-3259. PubMed ID: 38525973
[TBL] [Abstract][Full Text] [Related]
10. Safety and dosing of bevacizumab (avastin) for the treatment of recurrent respiratory papillomatosis.
Best SR; Friedman AD; Landau-Zemer T; Barbu AM; Burns JA; Freeman MW; Halvorsen YD; Hillman RE; Zeitels SM
Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):587-93. PubMed ID: 23012897
[TBL] [Abstract][Full Text] [Related]
11. Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
Tkaczuk A; Trivedi S; Mody MD; Steuer CE; Shin DM; Klein AM; Saba NF
Laryngoscope; 2021 Mar; 131(3):E921-E928. PubMed ID: 33107615
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
So RJ; Hidalgo Lopez JC; Ballestas SA; Klein AM; Steuer C; Shin DM; Abousaud M; Teng Y; Saba NF; Tkaczuk AT; Schaefer ES; Seiwert TY; McClellan K; Best SR
Laryngoscope; 2024 Feb; 134(2):577-581. PubMed ID: 37470254
[TBL] [Abstract][Full Text] [Related]
13. Systemic bevacizumab for recurrent respiratory papillomatosis.
Baday YI; Ongkasuwan J; Venkatramani R
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110352. PubMed ID: 32906078
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
Saito W; Kase S; Ohgami K; Mori S; Ohno S
Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
[TBL] [Abstract][Full Text] [Related]
15. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases.
Bedoya A; Glisinski K; Clarke J; Lind RN; Buckley CE; Shofer S
Am J Case Rep; 2017 Jul; 18():842-846. PubMed ID: 28757601
[TBL] [Abstract][Full Text] [Related]
16. Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: A series of three pediatric cases and literature review.
Enrique OH; Eloy SH; Adrian TP; Perla V
Am J Otolaryngol; 2021; 42(5):103126. PubMed ID: 34175693
[TBL] [Abstract][Full Text] [Related]
17. [Tracheobronchial and pulmonary papillomatosis without involvement of the larynx treated with intravenous Bevacizumab in a child].
Cuestas G; Rodríguez V; Doormann F; Bellia Munzón P; Bellia Munzón G
Arch Argent Pediatr; 2019 Feb; 117(1):e72-e76. PubMed ID: 30652461
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review.
Pogoda L; Ziylan F; Smeeing DPJ; Dikkers FG; Rinkel RNPM
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4229-4240. PubMed ID: 35462578
[TBL] [Abstract][Full Text] [Related]
19. Recurrent respiratory papillomatosis: update 2008.
Gallagher TQ; Derkay CS
Curr Opin Otolaryngol Head Neck Surg; 2008 Dec; 16(6):536-42. PubMed ID: 19005325
[TBL] [Abstract][Full Text] [Related]
20. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis.
Mohr M; Schliemann C; Biermann C; Schmidt LH; Kessler T; Schmidt J; Wiebe K; Müller KM; Hoffmann TK; Groll AH; Werner C; Kessler C; Wiewrodt R; Rudack C; Berdel WE
Oncol Lett; 2014 Nov; 8(5):1912-1918. PubMed ID: 25289079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
